IDX — Integral Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$785.95m
- AU$1.34bn
- AU$788.74m
Annual cashflow statement for Integral Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | C2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -5.42 | -3.66 | -1.24 | -19.5 | -2.2 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 37.1 | 67.1 | 66.2 | 73.8 | 95.2 |
| Capital Expenditures | -27.8 | -44 | -23.9 | -59.8 | -49.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -27.9 | -85 | -4.03 | -5.23 | 0.319 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -55.7 | -129 | -27.9 | -65 | -49.3 |
| Financing Cash Flow Items | -2.88 | — | — | — | 2.88 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 81.1 | -27.6 | -29.5 | 0.71 | -45.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 61 | -89.3 | 8.58 | 9.67 | -0.818 |